Vietnam Insulin Drug And Delivery Device Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Vietnam Insulin Drug and Delivery device market is segmented into type (basal or long-acting insulins, bolus or fast-acting insulins, traditional human insulins, combination insulins, and biosimilar insulins), device type (insulin pens, insulin pumps, insulin syringes, and jet injectors). The report offers the value (in USD million) and volume (in Units million) for the above segments.

Vietnam Insulin Drug And Delivery Device Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Vietnam Insulin Drug And Delivery Device Industry Overview

The market is highly consolidated, with three major manufacturers holding a global market presence and the remaining manufacturers confined to other local or region-specific manufacturers. Mergers and acquisitions that happened between the players in the recent past have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have the alliance to develop and commercialize Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.

Vietnam Insulin Drug And Delivery Device Market Leaders

  1. Novo Nordisk

  2. Sanofi

  3. Eli Lilly

  4. Medtronics

  5. Roche

  6. *Disclaimer: Major Players sorted in no particular order
Vietnam Insulin Drug And Delivery Device Market Concentration

Vietnam Insulin Drug And Delivery Device Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?